Episodes of acute DIOS · adults and children with cystic fibrosis
1 finding from 1 review
Adverse effects: abdominal mass · adults and children with cystic fibrosis
1 finding from 1 review
Abdominal pain · adults and children with cystic fibrosis
1 finding from 1 review
Mood or personal well‐being · adults and children with hemophilia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Coping strategies · adults and children with hemophilia
1 finding from 1 review
QoL · adults and children with hemophilia
1 finding from 1 review
Physical health: pain intensity (VAS post‐treatment scores) · adults and children with hemophilia
1 finding from 1 review
Family adjustment · adults and children with hemophilia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of hepatic veno‐occlusive disease ( · Patients undergoing stem cell transplant with malignant and non‐malignant diseases
It is very uncertain whether summary of findings: Antithrombin III plus heparin changes incidence of hepatic veno‐occlusive disease ( compared with heparin alone (very low certainty).
1 finding from 1 review
Overall survival · Patients undergoing stem cell transplant with malignant and non‐malignant diseases
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality at 100 days post‐transplant · Patients undergoing stem cell transplant with malignant and non‐malignant diseases
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality attributable to hepatic veno‐occlusive disease ( · Patients undergoing stem cell transplant with malignant and non‐malignant diseases
It is very uncertain whether summary of findings: Antithrombin III plus heparin changes mortality attributable to hepatic veno‐occlusive disease ( compared with heparin alone (very low certainty).
1 finding from 1 review
Quality of life · Patients undergoing stem cell transplant with malignant and non‐malignant diseases
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Frequency of adverse events ( · Patients undergoing stem cell transplant with malignant and non‐malignant diseases
It is very uncertain whether summary of findings: Antithrombin III plus heparin changes frequency of adverse events ( compared with heparin alone (very low certainty).
1 finding from 1 review
Pain (PIPP) · neonates
3 findings from 1 review
no estimate extracted
7 studies · 547 participants
Moderate
no estimate extracted
3 studies · 227 participants
Low
no estimate extracted
2 studies · 164 participants
Moderate
PIPP ‐ Preterm infants · neonates
1 finding from 1 review
DAN scores at 30 seconds after heel lancing (term infants)Scale from: 0 to 10 · neonates
1 finding from 1 review
Neonatal Infant Pain Scale (NIPS) · neonates
1 finding from 1 review
Depression symptoms ‐ short‐term · health problem or population
1 finding from 1 review
Depression remission · health problem or population
Summary of findings table ‐ Psychological treatment showed no clear difference in depression remission ‐ short term compared with control (low certainty).
1 finding from 1 review